Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

Vaccine

Volumn 14, Issue 4, 1996, Pages 337-343

  Pittman, Phillip R ^a   Makuch, Richard S ^a   Mangiafico, Joseph A ^a   Cannon, Timothy L ^a   Gibbs, Paul H ^a   Peters, Clarence J ^a,b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

C 84; TC 83; VEE vaccines; Venezuelan Equine Encephalitis (VEE) virus

Indexed keywords

VIRUS VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS INFECTION;

EID: 0029960102     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00168-Z     Document Type: Article

References (17)

1. Johnson, K.M. and Martin, D.H. Venezuelan equine encephalitis. Adv. Vet. Sci. Comp. Med. 1974, 18, 79-116
2. Peters, C.J. and Dalrymple, J.M. Alphaviruses. In: Virology, 2nd Edn (Eds Fields, B.N. et al.). Raven Press, New York, 1990, pp. 713-761
3. Johnson, K.M., Shelekov, A. Peralta, Dammin G.J. and Young, N.A. Recovery of Venezuelan equine encephalitis virus in Panama. Am. J. Trop. Med. Hyg. 1968, 17, 432-440
4. Kubes, V. and Rios, F.A. The causative agent of infectious equine encephalitis in Venezuela. Science 1939, 90, 20-21
5. McKinney, R.W. Inactivated and live VEE vaccines - a review. In: Proceedings of the workshop symposium on Venezuelan encephalitis. PAHO 1972, 369-389
6. Berge, T.O., Banks, I.S. and Tigertt, W.D. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am. J. Hyg. 1961, 73, 209-218
7. McKinney, R.W., Berge, T.O., Sawyer, W.O., Tigertt, W.D. and Crozier, D. Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man. Am. J. Trop. Med. Hyg. 1963, 12, 597-603
8. Casamassima, A.C., Hess, L.W. and Marty, A. TC-83 Venezuelan equine encephalitis exposure during pregnancy. Teratology 1987, 36, 287-289
9. Cole, F.E., May, S.W. and Eddy, G.A. Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus. Appl. Microbiol. 1974, 27, 150-153
10. Edelman, R. et al. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J. Infect. Dis. 1979, 140, 708-715
11. Jahrling, P.B. and Stephenson, E.H. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan Equine Encephalitis Virus vaccines against aerosol challenge in hamsters. J. Clin. Microbiol. 1984, 19, 429-431
12. Centers for Disease Control and National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories, 3rd Edn. US Department of Health and Human Services, Public Health Service, 1993, pp. 130-132
13. Burke, D.S., Ramsburg, H.H. and Edelman, R. Persistence in humans of antibody subtypes of Venezuelan equine encephalitis (VEE) after immunization with attenuated (TC-83) VEE virus vaccine. J. Infect. Dis. 1977, 136, 354-359
14. Kaplan, E.L. and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53, 1958 457-481
15. Bartelloni, P.J. Annual Report. US Army Medical Research Institute of Infectious Diseases, Frederick, MD, 1970
16. London, W.T., Levitt, N.H., Kent, S.G., Wong, V.G. and Sever, J.L. Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan Equine Encephalitis Virus. Teratology 1977, 16, 285-296
17. Davis, N.L. et al. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encepahlitis virus: construction of single and multiple mutants in a full-length CDNA clone. Virology 1991, 183, 20-31